Eli Lilly committed $6 billion to a new plant in Alabama, establishing a drug-discovery lab with Abiomed strength.
1 report, 1 independent
Updated Jul 4
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Eli Lilly committed $6 billion to a new plant in Alabama, establishing a drug-discovery lab with Abiomed strength.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Eli Lilly and Company
American pharmaceutical company
-
AbioMed
medical devices company based in Danvers, Massachusetts, USA
Nothing else this week.
-
Alabama
state of the United States of America
Related events
- Eli Lilly and Company plans to acquire Merida Biosciences for up to $2.8 billion in cash.
- Eli Lilly and Company is collaborating with Nvidia and OpenAI to build an AI lab aimed at accelerating drug discovery.
- An experimental drug, sourced from China, is under FDA scrutiny after marketing claims of being 'the ultimate good' and subsequent warnings were issued.
- Eli Lilly and Company plans to submit a drug candidate to the FDA for review and approval.
- Eli Lilly received approval for a plant development in Pennsylvania and paid a milestone payment to Nxera Pharma.